国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
卡培他滨治疗胃癌疗效及安全性的系统评价
Systematic Review on Therapeutic Effect and Safety Evaluation of Capecitabine in Patients with Gastric Carcinoma
  
DOI:
中文关键词:  Meta分析  胃癌  卡培他滨  药品安全性  随机对照实验
英文关键词:Meta analysis  Gastric carcinoma  Capecitabine  Drug safety  Randomized controlled
基金项目:国家社科基金资助项目(编号:13BGL132)
作者单位
郭佳栋 西安交通大学医学部药学院(西安 710061) 
冯变玲 西安交通大学医学部药学院 
张雪梅 西安交通大学医学部药学院 
蔡佳慧 西安交通大学医学部公共卫生学院 
赵妍 西安交通大学医学部公共卫生学院 
王丽云 西安交通大学医学部公共卫生学院 
摘要点击次数: 1509
全文下载次数: 1661
中文摘要:
      摘 要 目的:系统评价胃癌患者使用卡培他滨的疗效和安全性。方法:检索国内外发表的关于卡培他滨治疗胃癌的中英文文献,对符合纳入标准的随机对照试验进行系统评价。结果:最终纳入8篇文献,合计427例患者。卡培他滨单药与替吉奥、多西他赛+顺铂比较疗效,差异无统计学意义(P>0.05)。卡培他滨单药发生口腔黏膜炎(26.7%)和手足综合症(49.8%)的频率较高;替吉奥给药方案与卡培他滨单药相比毒性小;多西他赛+顺铂给药更易发生恶心/呕吐(P<0.05;卡培他滨+奥沙利铂给药更易发生白细胞减少(P<0.05);FOLFOX4给药更易发生白细胞减少(P<0.05)和恶心/呕吐(P<0.05)。结论:常规剂量下替吉奥与卡培他滨单药相比毒性更小,卡培他滨发生口腔黏膜炎和手足综合征的频率较高。总体而言,卡培他滨单药给药安全性较好。
英文摘要:
      ABSTRACT Objective: Systematically review on therapeutic effect and chemotherapy safety of capecitabine in the treatment of the gastric carcinoma patients.Methods:Chinese and foreign related literature about capecitabine in the treatment of the gastric carcinoma patients were retrieved, systematic review of randomized controlled trial which was included in the studies. Results: 8 literature and about 427 patients were chosen from all the papers. Into the study through the analysis, there was no significant difference between capecitabine, S-1, docetaxel and cisplatin about the treatment effect(P>0.05). Patients with capecitabine single agent, stomatitis(26.7%) and hand foot syndrome(49.8%) occurred more often; results were better when S-1 dosage regimen compared with capecitabine single agent, patients use capecitabine and cisplatin was more vulnerable to have nausea/vomiting(P<0.05); leukopenia occurred more often when patient have capecitabine and oxaliplatin(P<0.05), nausea/vomiting(P<0.05) and leukopenia(P<0.05) occurred more often when patient had FOLFOX4. Conclusion:Results were better when S 1 dosage regimen compared with capecitabine single agent. Stomatitis and hand foot syndrome occurred more often when used capecitabine. In conclusion, the safety of the capecitabine was acceptable.
查看全文  查看/发表评论  下载PDF阅读器
关闭